Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
SWK Stanley delivers 268 percent Q1 2026 EPS beat shares rise 047 percent in todays trading What makes LEIFRAS LFS a safer bet than newer entrants 657 20260506 ServiceNow Inc NOW Recent Price Pullback and Fundamental Outlook for NearTerm Investors Should you add Fresh Del FDP to your watchlist today Near Highs 20260508 Superyacht Season Kicks Off in Cannes Luxury Spending and Carbon Debt in Focus Timex Group India Posts Rs 800 Crore Revenue in FY26 Profit Surges 151 Oil Prices Edge Higher as USIran Talks Show Limited Progress After IBM US Government Stake Next Traders Bet on IonQ and Anduril Industries Tata Motors MD Says No GST Cut Needed for FlexFuel Vehicles Amid Fuel Price Concerns US Investment Funds Build Cash Reserves Ahead of Anticipated SpaceX and OpenAI Public Offerings RGR Q1 2026 Earnings EPS Misses Estimates Amid Modest Stock Uptick XOMAP Q1 2026 Earnings Preferred Stock Reports EPS Miss Amid Royalty Revenue Uncertainty ATNM Q1 2026 Earnings NarrowerthanExpected Loss Highlights Controlled Spending Amid Clinical Progress ADXN Q1 2024 Earnings ClinicalStage Biotech Reports Net Loss as Pipeline Advances SCCO Q1 2026 Earnings Strong EPS Beat Highlights Operational Efficiency RMBS Q1 2026 Earnings EPS Miss Sends Shares Lower Mustang Bio MBIO Edges Higher Biotech Stock Testing Key Resistance at 067 Kymera Therapeutics KYMR Slips Over 2 as Biotech Shares Retreat Support Levels in Focus Ingersoll Rand IR Holds Steady Near MidRange as Market Digests Mixed Signals NeOnc Technologies Holdings NTHI Holds Near Support as Modest Decline Tests Key Level Gevo Inc GEVO Rallies 472 as Renewable Energy Stock Tests Key Resistance CLMB Q1 2026 Earnings EPS Misses Estimates Despite Positive Stock Reaction RDZN Q1 2026 Earnings Significant EPS Miss Raises Concerns SPOK Q1 2026 Earnings EPS Misses Estimates by Over 50 Shares Dip 21 PureTech Health Q4 2024 Earnings EPS Misses Estimates as ClinicalStage Biotech Reports Results GTES Q1 2026 Earnings EPS Surpasses Estimates by 47 OCS Q1 2026 Earnings WiderthanExpected Loss Despite Pipeline Progress